منابع مشابه
Institutional Review Boards and Independent Ethics Committees
Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) are charged with protecting the rights and safety of clinical trial participants. The regulations that guide the review, approval, and conduct of human research refer to these independent boards as IRBs or IECs. In 2001 the Association for the Accreditation of Human Research Protection Programs (AAHRPP) was formed. Sinc...
متن کاملInstitutional review boards: consideration in developing countries.
547 emphasis on partnerships, decision-making by African scientists, and a strong scientific basis for the funded research. To support a variety of research programs, MIM has also developed the Malaria Research and Reference Reagent Resource Center, which provides high quality reagents and materials to investigators who are, or wish to be, involved in malaria research. NIH's National Library of...
متن کاملThe role of institutional review boards.
The author responds: I totally agree with the reader’s statement that a researcher’s ethics are the first line of research protection for human subjects. However, the IRB mechanism is our regulatory system that attempts to ensure this process. My statement in the article is framed on the basis of the current rash of highly publicized ethical violations by researchers. We need the first line che...
متن کاملInstitutional review boards - a mixed blessing
Institutional Review Boards (IRBs) are an important checkpoint for all types of research in medicine. Although these bodies originated primarily in the developed world, they have special contemporary consideration in the context of developing countries due to the large number of clinical trials being conducted in these regions with the financial support of large pharmaceutical companies. IRBs a...
متن کاملHow Can Institutional Review Boards Best Interpret Preclinical Data?
Among the many challenges facing institutional review boards (IRBs) is to predict whether the activities and interventions proposed in a clinical trial protocol are likely to yield net harm or net benefit for trial participants. IRBs take these questions very seriously, and never more so than in the review of first-inhuman (FIH) trials, where interpreting findings about risks to humans from ani...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2015
ISSN: 0012-3692
DOI: 10.1378/chest.15-0706